NCT02455453View on ClinicalTrials.gov

Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

April 28, 2015

Primary Completion Date

January 3, 2019

Study Completion Date

January 3, 2019

Conditions
Breast Cancer
Interventions
DRUG

18F-FFNP

DEVICE

CTI/Siemens Biograph 40 PET/CT Scanner

"* Will include (1) 18-FDG-PET/CT scan~* Will include (2) 18F-FFNP-PET/CT scans"

DRUG

Estradiol

DRUG

18F-FDG

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT02455453 - Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography | Biotech Hunter | Biotech Hunter